RESMED INC
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Financial Statements and Supplementary Data
| PART II | Item 8 |
|---|---|
| RESMED INC. AND SUBSIDIARIES | |
ITEM 8 CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The information required by this Item is incorporated by reference to the financial statements set forth in Item 15 of Part IV of this report, “Exhibits and Consolidated Financial Statement Schedules.”
(a) Index to Consolidated Financial Statements
| Report of Independent Registered Public Accounting Firm (KPMG LLP, San Diego, CA, Auditor Firm ID: 185) | 74 |
|---|---|
| Consolidated Balance Sheets as of June 30, 2026 and 2025 | 76 |
| Consolidated Statements of Income for the years ended June 30, 2026, 2025 and 2024 | 77 |
| Consolidated Statements of Comprehensive Income for the years ended June 30, 2026, 2025 and 2024 | 78 |
| Consolidated Statements of Stockholders’ Equity for the years ended June 30, 2026, 2025 and 2024 | 79 |
| Consolidated Statements of Cash Flows for the years ended June 30, 2026, 2025 and 2024 | 80 |
| Notes to Consolidated Financial Statements | 82 |
| Schedule II – Valuation and Qualifying Accounts and Reserves | 112 |
(b) Supplementary Data
Quarterly Financial Information (unaudited)—The quarterly results for the years ended June 30, 2026 and 2025 are summarized below (in thousands, except per share amounts):
| 2026 | FirstQuarter | SecondQuarter | ThirdQuarter | FourthQuarter | FiscalYear |
|---|---|---|---|---|---|
| Net revenue | $1,335,582 | $1,422,808 | $1,431,406 | $1,463,647 | $5,653,443 |
| Gross profit | $820,820 | $878,724 | $890,979 | $861,216 | $3,451,739 |
| Net income | $348,536 | $392,593 | $398,732 | $383,432 | $1,523,293 |
| Basic earnings per share | $2.38 | $2.69 | $2.74 | $2.65 | $10.47 |
| Diluted earnings per share | $2.37 | $2.68 | $2.74 | $2.64 | $10.43 |
| 2025 | FirstQuarter | SecondQuarter | ThirdQuarter | FourthQuarter | FiscalYear |
|---|---|---|---|---|---|
| Net revenue | $1,224,509 | $1,282,089 | $1,291,736 | $1,347,993 | $5,146,327 |
| Gross profit | $717,219 | $751,275 | $766,409 | $820,070 | $3,054,970 |
| Net income | $311,355 | $344,622 | $365,041 | $379,705 | $1,400,723 |
| Basic earnings per share | $2.12 | $2.35 | $2.49 | $2.59 | $9.55 |
| Diluted earnings per share | $2.11 | $2.34 | $2.48 | $2.58 | $9.51 |
Note: the amounts for each quarter are computed independently and, due to the computation formula, the sum of the four quarters may not equal the year.
-73-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.